Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects motor neurons resulting in progressive muscle atrophy. The heterogeneous nature of disease progression has limited the reliability and robustness of current clinical indicators used in disease monitoring. To address the need for reproducible, quantitative biomarkers, we propose the applicability of Magnetic Resonance Cytography (MRC) to characterize ALS induced changes to muscle myofiber microstructure. In this clinical study, the role of MRC as a potential biomarker was demonstrated by identifying changes to muscle cytoarchitecture in the lower extremities among ALS patients when compared with healthy muscle.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords